These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||||
|
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||||
|
|
|
||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
|
|
|||||
|
|
|||||
| (Address of principal executive offices) (Zip Code) | |||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
|
|
☒
|
Accelerated filer | ☐ | ||||||||
| Non-accelerated filer | ☐ | Smaller reporting company |
|
||||||||
| Emerging growth company |
|
||||||||||
| Page | |||||
| September 30, 2022 | December 31, 2021 | |||||||||||||
| Assets | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||||||||
| Receivables, net |
|
|
||||||||||||
| Inventories |
|
|
||||||||||||
| Prepaid expenses and other current assets |
|
|
||||||||||||
| Assets of discontinued operations |
|
|
||||||||||||
| Total current assets |
|
|
||||||||||||
| Property, plant, and equipment, net |
|
|
||||||||||||
| Operating lease right-of-use assets |
|
|
||||||||||||
| Goodwill |
|
|
||||||||||||
| Intangible assets, net |
|
|
||||||||||||
| Other assets, net |
|
|
||||||||||||
| Total assets | $ |
|
$ |
|
||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | $ |
|
$ |
|
||||||||||
| Accrued expenses |
|
|
||||||||||||
| Current portion of long-term debt |
|
|
||||||||||||
| Liabilities of discontinued operations |
|
|
||||||||||||
| Total current liabilities |
|
|
||||||||||||
| Long-term debt |
|
|
||||||||||||
| Operating lease liabilities |
|
|
||||||||||||
| Deferred income taxes |
|
|
||||||||||||
| Other long-term liabilities |
|
|
||||||||||||
| Total liabilities |
|
|
||||||||||||
|
Commitments and contingencies (Note 18)
|
|
|
||||||||||||
| Stockholders' equity: | ||||||||||||||
|
Preferred stock, par value $
|
|
|
||||||||||||
|
Common stock, par value $
|
|
|
||||||||||||
| Treasury stock |
(
|
(
|
||||||||||||
| Additional paid-in capital |
|
|
||||||||||||
| Accumulated deficit |
(
|
(
|
||||||||||||
| Accumulated other comprehensive loss |
(
|
(
|
||||||||||||
| Total stockholders' equity |
|
|
||||||||||||
| Total liabilities and stockholders' equity | $ |
|
$ |
|
||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Cost of sales |
|
|
|
|
||||||||||||||||||||||
| Gross profit |
|
|
|
|
||||||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||||
| Selling and distribution |
|
|
|
|
||||||||||||||||||||||
| General and administrative |
|
|
|
|
||||||||||||||||||||||
| Amortization expense |
|
|
|
|
||||||||||||||||||||||
| Other operating expense, net |
|
|
|
|
||||||||||||||||||||||
| Total operating expenses |
|
|
|
|
||||||||||||||||||||||
| Operating (loss) income |
(
|
|
(
|
(
|
||||||||||||||||||||||
| Other expense (income): | ||||||||||||||||||||||||||
| Interest expense |
|
|
|
|
||||||||||||||||||||||
| Loss on extinguishment of debt |
|
|
|
|
||||||||||||||||||||||
| Loss (gain) on foreign currency exchange |
|
|
|
(
|
||||||||||||||||||||||
| Other income, net |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Total other expense (income) |
|
|
(
|
|
||||||||||||||||||||||
| Loss before income taxes |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Income tax expense (benefit) |
|
(
|
(
|
(
|
||||||||||||||||||||||
| Net loss from continuing operations |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Net (loss) income from discontinued operations |
(
|
|
(
|
|
||||||||||||||||||||||
| Net (loss) income | $ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
| Earnings (loss) per common share - basic: | ||||||||||||||||||||||||||
| Continuing operations | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Discontinued operations |
(
|
|
(
|
|
||||||||||||||||||||||
|
Earnings (loss) per share basic
(1)
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
| Earnings (loss) per common share - diluted: | ||||||||||||||||||||||||||
| Continuing operations | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Discontinued operations |
(
|
|
(
|
|
||||||||||||||||||||||
|
Earnings (loss) per share diluted
(1)
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
| Weighted average common shares: | ||||||||||||||||||||||||||
| Basic |
|
|
|
|
||||||||||||||||||||||
| Diluted |
|
|
|
|
||||||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
| Net (loss) income | $ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
| Other comprehensive (loss) income: | ||||||||||||||||||||||||||
| Foreign currency translation adjustments |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Pension and postretirement reclassification adjustment |
|
|
|
|
||||||||||||||||||||||
| Other comprehensive loss |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Comprehensive (loss) income | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||
| Accumulated | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Additional | Other | |||||||||||||||||||||||||||||||||||||||||||||||||
| Common Stock | Paid-In | Accumulated | Treasury Stock | Comprehensive | Total | |||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Capital | Deficit | Shares | Amount | Loss | Equity | |||||||||||||||||||||||||||||||||||||||||||
| Balance, January 1, 2021 |
|
$ |
|
$ |
|
$ |
(
|
(
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
| Net income | — | — | — |
|
— | — | — |
|
||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock awards |
|
— |
(
|
— | — | — | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||||||||||
| Balance, March 31, 2021 |
|
$ |
|
$ |
|
$ |
(
|
(
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
| Net income | — | — | — |
|
— | — | — |
|
||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||||||||||||
| Treasury stock repurchases | — | — | — | — |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock awards | — | — |
(
|
— | — | — | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||||||||||
| Balance, June 30, 2021 |
|
$ |
|
$ |
|
$ |
(
|
(
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
| Net income | — | — | — |
|
— | — | — |
|
||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock awards |
|
— |
(
|
— | — | — | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||||||||||
| Balance, September 30, 2021 |
|
$ |
|
$ |
|
$ |
(
|
(
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
| Balance, January 1, 2022 |
|
$ |
|
$ |
|
$ |
(
|
(
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — |
(
|
— | — | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock awards |
|
— |
(
|
— | — | — | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||||||||||
| Balance, March 31, 2022 |
|
$ |
|
$ |
|
$ |
(
|
(
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — |
(
|
— | — | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||||||||||
| Balance, June 30, 2022 |
|
$ |
|
$ |
|
$ |
(
|
(
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — |
(
|
— | — | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock awards |
|
— |
(
|
— | — | — | — |
(
|
||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||||||||||
| Balance, September 30, 2022 |
|
$ |
|
$ |
|
$ |
(
|
(
|
$ |
(
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2022 | 2021 | |||||||||||||
| Cash flows from operating activities: | ||||||||||||||
| Net (loss) income | $ |
(
|
$ |
|
||||||||||
| Net (loss) income from discontinued operations |
(
|
|
||||||||||||
| Net loss from continuing operations |
(
|
(
|
||||||||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||||
| Depreciation and amortization |
|
|
||||||||||||
| Stock-based compensation |
|
|
||||||||||||
| Loss on extinguishment of debt |
|
|
||||||||||||
| Unrealized gain on derivative contracts |
(
|
(
|
||||||||||||
| Deferred income taxes |
|
(
|
||||||||||||
| Other |
|
|
||||||||||||
| Changes in operating assets and liabilities, net of acquisitions and divestitures: | ||||||||||||||
| Receivables |
(
|
|
||||||||||||
| Inventories |
(
|
(
|
||||||||||||
| Prepaid expenses and other assets |
|
(
|
||||||||||||
| Accounts payable |
|
|
||||||||||||
| Accrued expenses and other liabilities |
(
|
(
|
||||||||||||
| Net cash used in operating activities - continuing operations |
(
|
(
|
||||||||||||
| Net cash (used in) provided by operating activities - discontinued operations |
(
|
|
||||||||||||
| Net cash (used in) provided by operating activities |
(
|
|
||||||||||||
| Cash flows from investing activities: | ||||||||||||||
| Additions to property, plant, and equipment |
(
|
(
|
||||||||||||
| Additions to intangible assets |
(
|
(
|
||||||||||||
| Proceeds from sale of fixed assets |
|
|
||||||||||||
| Proceeds from sale of investments |
|
|
||||||||||||
| Net cash used in investing activities - continuing operations |
(
|
(
|
||||||||||||
| Net cash (used in) provided by investing activities - discontinued operations |
(
|
|
||||||||||||
| Net cash (used in) provided by investing activities |
(
|
|
||||||||||||
| Cash flows from financing activities: | ||||||||||||||
| Borrowings under Revolving Credit Facility |
|
|
||||||||||||
| Payments under Revolving Credit Facility |
(
|
(
|
||||||||||||
| Payments on financing lease obligations |
(
|
(
|
||||||||||||
| Payment of deferred financing costs |
(
|
(
|
||||||||||||
| Payments on Term Loans |
(
|
(
|
||||||||||||
| Proceeds from refinanced Term Loans |
|
|
||||||||||||
| Repurchase of Notes |
|
(
|
||||||||||||
| Payment of debt premium for extinguishment of debt |
|
(
|
||||||||||||
| Repurchases of common stock |
|
(
|
||||||||||||
| Payments related to stock-based award activities |
(
|
(
|
||||||||||||
| Net cash used in financing activities - continuing operations |
(
|
(
|
||||||||||||
| Net cash used in financing activities - discontinued operations |
(
|
(
|
||||||||||||
| Net cash used in financing activities |
(
|
(
|
||||||||||||
| Effect of exchange rate changes on cash and cash equivalents |
(
|
(
|
||||||||||||
| Net decrease in cash and cash equivalents |
(
|
(
|
||||||||||||
| Add: Cash and cash equivalents of discontinued operations, beginning of period |
|
|
||||||||||||
| Less: Cash and cash equivalents of discontinued operations, end of period |
(
|
(
|
||||||||||||
| Cash and cash equivalents, beginning of period |
|
|
||||||||||||
| Cash and cash equivalents, end of period | $ |
|
$ |
|
||||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2022 | 2021 | |||||||||||||
| Supplemental cash flow disclosures: | ||||||||||||||
| Interest paid | $ |
|
$ |
|
||||||||||
| Net income taxes (refunded) paid |
(
|
|
||||||||||||
| Non-cash investing activities: | ||||||||||||||
| Accrued purchase of property and equipment | $ |
|
$ |
|
||||||||||
| Accrued other intangible assets |
|
|
||||||||||||
| Right-of-use assets obtained in exchange for lease obligations |
|
|
||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
| Strategic Growth Initiatives | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Other |
|
|
|
|
||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||||||||
| Employee-related | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Other costs |
|
|
|
|
||||||||||||||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Severance | Retention | Total Exit Cost Liabilities | ||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
| Balance as of December 31, 2021 | $ |
|
$ |
|
$ |
|
||||||||||||||||||||
| Expenses recognized |
|
|
|
|||||||||||||||||||||||
| Cash payments |
(
|
(
|
(
|
|||||||||||||||||||||||
| Balance as of September 30, 2022 | $ |
|
$ |
|
$ |
|
||||||||||||||||||||
| Balance Sheet Classification | September 30, 2022 | December 31, 2021 | ||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Assets | ||||||||||||||||||||
| Operating | Operating lease right-of-use assets | $ |
|
$ |
|
|||||||||||||||
| Finance | Property, plant, and equipment, net |
|
|
|||||||||||||||||
| Total assets | $ |
|
$ |
|
||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Operating | Accrued expenses | $ |
|
$ |
|
|||||||||||||||
| Finance | Current portion of long-term debt |
|
|
|||||||||||||||||
| Total current liabilities |
|
|
||||||||||||||||||
| Noncurrent liabilities | ||||||||||||||||||||
| Operating | Operating lease liabilities |
|
|
|||||||||||||||||
| Finance | Long-term debt |
|
|
|||||||||||||||||
| Total noncurrent liabilities |
|
|
||||||||||||||||||
| Total lease liabilities | $ |
|
$ |
|
||||||||||||||||
| Weighted-average discount rate | September 30, 2022 | December 31, 2021 | ||||||||||||
| Operating leases |
|
% |
|
% | ||||||||||
| Finance leases |
|
% |
|
% | ||||||||||
| Weighted-average remaining lease term | September 30, 2022 | December 31, 2021 | ||||||||||||
| Operating leases |
|
|
||||||||||||
| Finance leases |
|
|
||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||
| Statement of Operations Classification | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||
| Operating lease cost | Cost of sales and General and administrative | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| Finance lease cost: | ||||||||||||||||||||||||||||||||
| Amortization of right-of-use assets | Cost of sales and General and administrative |
|
|
|
|
|||||||||||||||||||||||||||
| Interest on lease liabilities | Interest expense |
|
|
|
|
|||||||||||||||||||||||||||
| Total finance lease cost |
|
|
|
|
||||||||||||||||||||||||||||
| Variable lease cost (1) | Cost of sales and General and administrative |
|
|
|
|
|||||||||||||||||||||||||||
| Net lease cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||
| Operating Leases (1) | Finance Leases | |||||||||||||
| (In millions) | ||||||||||||||
| Three months ended December 31, 2022 | $ |
|
$ |
|
||||||||||
| 2023 |
|
|
||||||||||||
| 2024 |
|
|
||||||||||||
| 2025 |
|
|
||||||||||||
| 2026 |
|
|
||||||||||||
| Thereafter |
|
|
||||||||||||
| Total lease payments |
|
|
||||||||||||
| Less: Interest |
(
|
|
||||||||||||
| Present value of lease liabilities | $ |
|
$ |
|
||||||||||
| Nine Months Ended | Nine Months Ended | |||||||||||||
| September 30, 2022 | September 30, 2021 | |||||||||||||
| (In millions) | ||||||||||||||
| Cash paid for amounts included in the measurement of lease liabilities: | ||||||||||||||
| Operating cash flows from operating leases | $ |
|
$ |
|
||||||||||
| Financing cash flows from finance leases |
|
|
||||||||||||
| September 30, 2022 | December 31, 2021 | |||||||||||||
| (In millions) | ||||||||||||||
| Outstanding accounts receivable sold | $ |
|
$ |
|
||||||||||
| Receivables collected and not remitted to financial institutions |
|
|
||||||||||||
| Nine Months Ended September 30, | ||||||||||||||
| 2022 | 2021 | |||||||||||||
| (In millions) | ||||||||||||||
| Receivables sold | $ |
|
$ |
|
||||||||||
| Receivables collected and remitted to financial institutions |
(
|
(
|
||||||||||||
| September 30, 2022 | December 31, 2021 | |||||||||||||
| (In millions) | ||||||||||||||
| Raw materials and supplies | $ |
|
$ |
|
||||||||||
| Finished goods |
|
|
||||||||||||
| Total inventories | $ |
|
$ |
|
||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Cost of sales |
|
|
|
|
||||||||||||||||||||||
| Selling, general, administrative and other operating expenses |
|
|
|
|
||||||||||||||||||||||
| Amortization expense |
|
|
|
|
||||||||||||||||||||||
| Loss (gain) on sale of business |
|
|
|
(
|
||||||||||||||||||||||
| Operating income from discontinued operations |
(
|
|
(
|
|
||||||||||||||||||||||
| Interest and other expense |
|
|
|
|
||||||||||||||||||||||
| Income tax (benefit) expense |
|
|
|
|
||||||||||||||||||||||
| Net (loss) income from discontinued operations | $ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
| September 30, 2022 | December 31, 2021 | |||||||||||||
| (In millions) | ||||||||||||||
| Cash | $ |
|
$ |
|
||||||||||
| Receivables, net |
|
|
||||||||||||
| Inventories |
|
|
||||||||||||
| Prepaid expenses and other assets |
|
|
||||||||||||
| Property, plant, and equipment, net |
|
|
||||||||||||
| Operating lease right-of-use assets |
|
|
||||||||||||
| Goodwill |
|
|
||||||||||||
| Intangible assets, net |
|
|
||||||||||||
| Valuation allowance |
(
|
|
||||||||||||
| Total assets of discontinued operations | $ |
|
$ |
|
||||||||||
| Accounts payable | $ |
|
$ |
|
||||||||||
| Accrued expenses and other liabilities |
|
|
||||||||||||
| Operating lease liabilities |
|
|
||||||||||||
| Deferred income taxes |
|
|
||||||||||||
| Total liabilities of discontinued operations | $ |
|
$ |
|
||||||||||
| September 30, 2022 | December 31, 2021 | |||||||||||||
| (In millions) | ||||||||||||||
| Land | $ |
|
$ |
|
||||||||||
| Buildings and improvements |
|
|
||||||||||||
| Machinery and equipment |
|
|
||||||||||||
| Construction in progress |
|
|
||||||||||||
| Total |
|
|
||||||||||||
| Less accumulated depreciation |
(
|
(
|
||||||||||||
| Property, plant, and equipment, net | $ |
|
$ |
|
||||||||||
| Goodwill | ||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
| Balance at December 31, 2021, before accumulated impairment losses | $ |
|
||||||||||||||||||||||||
| Accumulated impairment losses |
(
|
|||||||||||||||||||||||||
| Balance at December 31, 2021 |
|
|||||||||||||||||||||||||
| Foreign currency exchange adjustments |
(
|
|||||||||||||||||||||||||
| Balance at September 30, 2022 | $ |
|
||||||||||||||||||||||||
| September 30, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Gross
Carrying Amount |
Accumulated
Amortization |
Net
Carrying Amount |
Gross
Carrying Amount |
Accumulated
Amortization |
Net
Carrying Amount |
||||||||||||||||||||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Intangible assets with finite lives: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Customer-related | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||||||
| Trademarks |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Formulas/recipes |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Computer software |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Total finite lived intangibles |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Intangible assets with indefinite lives: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trademarks |
|
— |
|
|
— |
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Total intangible assets | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||||||
| September 30, 2022 | December 31, 2021 | ||||||||||
| (In millions) | |||||||||||
| Payroll and benefits | $ |
|
$ |
|
|||||||
| Trade promotion liabilities |
|
|
|||||||||
| Operating lease liabilities |
|
|
|||||||||
| Interest |
|
|
|||||||||
| Taxes |
|
|
|||||||||
| Health insurance, workers' compensation, and other insurance costs |
|
|
|||||||||
| Derivative contracts |
|
|
|||||||||
| Other accrued liabilities |
|
|
|||||||||
| Total | $ |
|
$ |
|
|||||||
| September 30, 2022 | December 31, 2021 | |||||||||||||
| (In millions) | ||||||||||||||
| Term Loan A | $ |
|
$ |
|
||||||||||
| Term Loan A-1 |
|
|
||||||||||||
| 2028 Notes |
|
|
||||||||||||
| Finance leases |
|
|
||||||||||||
| Total outstanding debt |
|
|
||||||||||||
| Deferred financing costs |
(
|
(
|
||||||||||||
| Less current portion |
(
|
(
|
||||||||||||
| Total long-term debt | $ |
|
$ |
|
||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
| (In millions, except per share data) | ||||||||||||||||||||||||||
| Weighted average common shares outstanding |
|
|
|
|
||||||||||||||||||||||
| Assumed exercise/vesting of equity awards (1) |
|
|
|
|
||||||||||||||||||||||
| Weighted average diluted common shares outstanding |
|
|
|
|
||||||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Compensation expense related to stock-based payments | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Related income tax benefit |
|
|
|
|
||||||||||||||||||||||
|
Employee
Options |
Weighted
Average Exercise Price |
Weighted
Average Remaining Contractual Term (years) |
Aggregate
Intrinsic Value |
|||||||||||||||||||||||
| (In thousands) | (In millions) | |||||||||||||||||||||||||
| Outstanding, at December 31, 2021 |
|
$ |
|
|
$ |
|
||||||||||||||||||||
| Granted |
|
|
||||||||||||||||||||||||
| Forfeited |
(
|
|
||||||||||||||||||||||||
| Expired |
(
|
|
||||||||||||||||||||||||
| Outstanding, at September 30, 2022 |
|
|
|
|
||||||||||||||||||||||
| Vested/expected to vest, at September 30, 2022 |
|
|
|
|
||||||||||||||||||||||
| Exercisable, at September 30, 2022 |
|
|
|
|
||||||||||||||||||||||
|
Nine Months Ended
September 30, |
||||||||
| 2022 | ||||||||
| Dividend yield |
|
% | ||||||
| Risk-free rate |
|
% | ||||||
| Expected volatility |
|
% | ||||||
| Expected term (in years) |
|
|||||||
|
Employee
Restricted Stock Units |
Weighted
Average Grant Date Fair Value |
Director
Restricted Stock Units |
Weighted
Average Grant Date Fair Value |
|||||||||||||||||||||||
| (In thousands) | (In thousands) | |||||||||||||||||||||||||
| Nonvested, at December 31, 2021 |
|
$ |
|
|
$ |
|
||||||||||||||||||||
| Granted |
|
|
|
|
||||||||||||||||||||||
| Vested |
(
|
|
(
|
|
||||||||||||||||||||||
| Forfeited |
(
|
|
|
|
||||||||||||||||||||||
| Nonvested, at September 30, 2022 |
|
|
|
|
||||||||||||||||||||||
| Vested and deferred, at September 30, 2022 |
|
|
||||||||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Fair value of vested restricted stock units | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Tax benefit recognized from vested restricted stock units |
|
|
|
|
||||||||||||||||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2022 | 2021 | |||||||||||||
| Dividend yield |
|
% |
|
% | ||||||||||
| Risk-free rate |
|
% |
|
% | ||||||||||
| Expected volatility (TreeHouse Foods, Inc.) |
|
% |
|
% | ||||||||||
| Expected volatility (Peer Group) |
|
% |
|
% | ||||||||||
|
Expected volatility (Index)
|
|
% | N/A | |||||||||||
| Expected term (in years) |
|
|
||||||||||||
|
Performance
Units |
Weighted
Average Grant Date Fair Value |
|||||||||||||
| (In thousands) | ||||||||||||||
| Nonvested, at December 31, 2021 |
|
$ |
|
|||||||||||
| Granted |
|
|
||||||||||||
| Vested |
(
|
|
||||||||||||
| Forfeited |
(
|
|
||||||||||||
| Nonvested, at September 30, 2022 |
|
|
||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Fair value of vested performance units | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Tax benefit recognized from performance units vested |
|
|
|
|
||||||||||||||||||||||
|
Foreign
Currency Translation (1) |
Unrecognized
Pension and Postretirement Benefits (1) |
Accumulated
Other Comprehensive Loss |
||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Balance at December 31, 2020 | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
| Other comprehensive loss before reclassifications |
(
|
|
(
|
|||||||||||||||||
| Reclassifications from accumulated other comprehensive loss (2) |
|
|
|
|||||||||||||||||
| Other comprehensive (loss) income |
(
|
|
(
|
|||||||||||||||||
| Balance at September 30, 2021 | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
| Balance at December 31, 2021 | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
| Other comprehensive loss before reclassifications |
(
|
|
(
|
|||||||||||||||||
| Reclassifications from accumulated other comprehensive loss (2) |
|
|
|
|||||||||||||||||
| Other comprehensive (loss) income |
(
|
|
(
|
|||||||||||||||||
| Balance at September 30, 2022 | $ |
(
|
$ |
|
$ |
(
|
||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Service cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Interest cost |
|
|
|
|
||||||||||||||||||||||
| Expected return on plan assets |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Curtailment (1) |
|
(
|
|
(
|
||||||||||||||||||||||
| Amortization of unrecognized prior service cost |
|
|
|
|
||||||||||||||||||||||
| Amortization of unrecognized net loss |
|
|
|
|
||||||||||||||||||||||
| Net periodic pension benefit | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Interest cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Net periodic postretirement cost | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Restructuring (1) | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Other |
|
|
|
|
||||||||||||||||||||||
| Total other operating expense, net | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| September 30, 2022 | December 31, 2021 | |||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Asset derivatives | ||||||||||||||||||||
| Commodity contracts | $ |
|
$ |
|
||||||||||||||||
| Interest rate swap agreements |
|
|
||||||||||||||||||
| $ |
|
$ |
|
|||||||||||||||||
| Liability derivatives | ||||||||||||||||||||
| Commodity contracts | $ |
|
$ |
|
||||||||||||||||
| Interest rate swap agreements |
|
|
||||||||||||||||||
| Total return swap contract |
|
|
||||||||||||||||||
| $ |
|
$ |
|
|||||||||||||||||
| Location of Gain (Loss) |
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
||||||||||||||||||||||||||||||
| Recognized in Net Income (Loss) | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||||||||
| Mark-to-market unrealized gain (loss) | ||||||||||||||||||||||||||||||||
| Commodity contracts | Other income, net | $ |
(
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||||||
| Interest rate swap agreements | Other income, net |
|
|
|
|
|||||||||||||||||||||||||||
| Total return swap contract | General and administrative |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||
| Total unrealized gain | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||
| Realized gain (loss) | ||||||||||||||||||||||||||||||||
| Commodity contracts | Manufacturing related to Cost of sales and transportation related to Selling and distribution | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| Interest rate swap agreements | Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||
| Total return swap contracts | General and administrative |
(
|
|
(
|
|
|||||||||||||||||||||||||||
| Total realized gain (loss) | $ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||
| Total gain | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||
| Product Category Group | Principal Products | |||||||
| Snacking | Candy; cookies; crackers; in-store bakery items; pretzels; retail griddle waffles, pancakes, and French toast; and snack bars | |||||||
| Beverages & drink mixes | Broths/stocks; liquid and powdered non-dairy creamer; powdered beverages and other blends; ready-to-drink beverages; single serve hot beverages; and specialty teas | |||||||
| Grocery | Cheese & pudding; hot cereals; pickles; and refrigerated dough | |||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Snacking | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Beverages & drink mixes |
|
|
|
|
||||||||||||||||||||||
| Grocery |
|
|
|
|
||||||||||||||||||||||
| Total net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
| (In millions) | (In millions) | |||||||||||||||||||||||||
| Retail grocery | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Co-manufacturing |
|
|
|
|
||||||||||||||||||||||
| Food-away-from-home and other |
|
|
|
|
||||||||||||||||||||||
| Total net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
| 2022 | 2021 | % Change | 2022 | 2021 | % Change | |||||||||||||||||||||||||||||||||
| GAAP Results | ||||||||||||||||||||||||||||||||||||||
| Net sales | $875.0 | $751.7 | 16.4% | $2,457.8 | $2,129.6 | 15.4% | ||||||||||||||||||||||||||||||||
| Net loss from continuing operations | (15.1) | (4.1) | (268.3) | (56.2) | (50.1) | (12.2) | ||||||||||||||||||||||||||||||||
| Net (loss) income | (90.5) | 6.7 | (1,450.7) | (122.9) | 16.6 | (840.4) | ||||||||||||||||||||||||||||||||
| Diluted loss per share from continuing operations | (0.27) | (0.07) | (285.7) | (1.00) | (0.90) | (11.1) | ||||||||||||||||||||||||||||||||
|
Non-GAAP Results
(1)
|
||||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA from continuing operations | 76.6 | 85.8 | (10.7) | 167.0 | 218.5 | (23.6) | ||||||||||||||||||||||||||||||||
| Adjusted EBITDA | 89.4 | 106.9 | (16.4) | 213.3 | 304.2 | (29.9) | ||||||||||||||||||||||||||||||||
| Adjusted net income from continuing operations | 17.1 | 23.4 | (26.9) | 10.6 | 40.0 | (73.5) | ||||||||||||||||||||||||||||||||
| Adjusted diluted EPS from continuing operations | 0.30 | 0.42 | (28.6) | 0.19 | 0.71 | (73.2) | ||||||||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||||||||||||||||||||||||||
| Dollars | Percent | Dollars | Percent | Dollars | Percent | Dollars | Percent | |||||||||||||||||||||||||||||||||||||||||||
| (Dollars in millions) | (Dollars in millions) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 875.0 | 100.0 | % | $ | 751.7 | 100.0 | % | $ | 2,457.8 | 100.0 | % | $ | 2,129.6 | 100.0 | % | ||||||||||||||||||||||||||||||||||
| Cost of sales | 745.7 | 85.2 | 625.8 | 83.3 | 2,118.8 | 86.2 | 1,784.8 | 83.8 | ||||||||||||||||||||||||||||||||||||||||||
| Gross profit | 129.3 | 14.8 | 125.9 | 16.7 | 339.0 | 13.8 | 344.8 | 16.2 | ||||||||||||||||||||||||||||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Selling and distribution | 52.0 | 5.9 | 50.1 | 6.7 | 167.9 | 6.8 | 143.8 | 6.8 | ||||||||||||||||||||||||||||||||||||||||||
| General and administrative | 51.5 | 5.9 | 38.1 | 5.1 | 160.5 | 6.5 | 142.0 | 6.7 | ||||||||||||||||||||||||||||||||||||||||||
| Amortization expense | 11.9 | 1.4 | 11.8 | 1.6 | 35.7 | 1.5 | 35.4 | 1.7 | ||||||||||||||||||||||||||||||||||||||||||
| Other operating expense, net | 23.4 | 2.7 | 16.9 | 2.2 | 66.4 | 2.7 | 57.8 | 2.7 | ||||||||||||||||||||||||||||||||||||||||||
| Total operating expenses | 138.8 | 15.9 | 116.9 | 15.6 | 430.5 | 17.5 | 379.0 | 17.9 | ||||||||||||||||||||||||||||||||||||||||||
| Operating (loss) income | (9.5) | (1.1) | 9.0 | 1.1 | (91.5) | (3.7) | (34.2) | (1.7) | ||||||||||||||||||||||||||||||||||||||||||
| Other expense (income): | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest expense | 17.5 | 2.0 | 16.5 | 2.2 | 51.2 | 2.1 | 55.5 | 2.6 | ||||||||||||||||||||||||||||||||||||||||||
| Loss on extinguishment of debt | — | — | — | — | — | — | 14.4 | 0.7 | ||||||||||||||||||||||||||||||||||||||||||
| Loss (gain) on foreign currency exchange | 3.0 | 0.3 | 0.6 | 0.1 | 3.0 | 0.1 | (0.3) | — | ||||||||||||||||||||||||||||||||||||||||||
| Other income, net | (16.9) | (1.9) | (3.6) | (0.5) | (84.7) | (3.4) | (38.7) | (1.8) | ||||||||||||||||||||||||||||||||||||||||||
| Total other expense (income) | 3.6 | 0.4 | 13.5 | 1.8 | (30.5) | (1.2) | 30.9 | 1.5 | ||||||||||||||||||||||||||||||||||||||||||
| Loss before income taxes | (13.1) | (1.5) | (4.5) | (0.7) | (61.0) | (2.5) | (65.1) | (3.2) | ||||||||||||||||||||||||||||||||||||||||||
| Income tax expense (benefit) | 2.0 | 0.2 | (0.4) | (0.1) | (4.8) | (0.2) | (15.0) | (0.7) | ||||||||||||||||||||||||||||||||||||||||||
| Net loss from continuing operations | (15.1) | (1.7) | (4.1) | (0.6) | (56.2) | (2.3) | (50.1) | (2.5) | ||||||||||||||||||||||||||||||||||||||||||
| Net (loss) income from discontinued operations | (75.4) | (8.6) | 10.8 | 1.4 | (66.7) | (2.7) | 66.7 | 3.1 | ||||||||||||||||||||||||||||||||||||||||||
| Net (loss) income | $ | (90.5) | (10.3) | % | $ | 6.7 | 0.8 | % | $ | (122.9) | (5.0) | % | $ | 16.6 | 0.6 | % | ||||||||||||||||||||||||||||||||||
| Dollars | Percent | |||||||||||||
| (In millions) | ||||||||||||||
| 2021 Net sales | $ | 751.7 | ||||||||||||
| Pricing | 155.8 | 20.7 | % | |||||||||||
| Volume/mix | (31.3) | (4.2) | ||||||||||||
| Foreign currency | (1.2) | (0.1) | ||||||||||||
| 2022 Net sales | $ | 875.0 | 16.4 | % | ||||||||||
| Foreign currency | 0.1 | |||||||||||||
| Percent change in organic net sales (1) | 16.5 | % | ||||||||||||
|
The net sales increase of 16.4% was primarily driven by favorable pricing to recover commodity inflation. This was partially offset by labor and supply chain disruption, which constrained our ability to service demand. Additionally, decreases in volume were due to exiting lower margin business particularly in Pickles.
|
||
|
Gross Profit
— Gross profit as a percentage of net sales was 14.8% in the third quarter of 2022, compared to 16.7% in the third quarter of 2021, a decrease of 1.9 percentage points. The decrease is primarily due to incremental costs related to labor and supply chain disruption as a result of the macro environment as well as warehouse capacity challenges. This was partially offset by the Company's pricing actions to recover commodity and freight inflation experienced in prior periods and favorable category mix.
|
||
|
Total Operating Expenses
— Total operating expenses were $138.8 million in the third quarter of 2022 compared to $116.9 million in the third quarter of 2021, an increase of $21.9 million. The increase is primarily attributable to higher employee compensation costs to address retention and labor shortages. Professional fees increased in connection with set-up costs for a transition services agreement as part of the sale of a significant portion of the Meal Preparation business, and other divestiture related restructuring costs contributed to the increase. This was partially offset by lower spend in the strategic growth initiatives and other restructuring programs, which consisted primarily of professional fees.
|
||
|
Total Other Expense (Income)
—
Total other expense (income) was $3.6 million in the third quarter of 2022 compared to $13.5 million in the third quarter of 2021, a decrease of $9.9 million. The decrease was primarily due to favorable non-cash mark-to-market impacts from hedging activities, largely driven by interest rate swaps due to rising interest rates. This was partially offset by unfavorable foreign currency exchange rate impacts between the U.S. and Canadian dollar.
|
||
|
Income Taxes
— Income taxes were recognized at an effective rate of (15.3)% in the third quarter of 2022 compared to 8.9% recognized in the third quarter of 2021. The change in the Company's effective tax rate is primarily driven by a change in the valuation allowance recorded against certain deferred tax assets, tax expense recognized in 2022 due to the restructuring of certain Canadian subsidiaries, and tax expense recognized in 2021 due to the enactment of the CARES Act.
|
||
| Our effective tax rate may change from period to period based on recurring and non-recurring factors including the jurisdictional mix of earnings, enacted tax legislation, state income taxes, settlement of tax audits, and the expiration of the statute of limitations in relation to unrecognized tax benefits. | ||
|
Discontinued Operations
— Net (loss) income from discontinued operations was a $75.4 million loss in the third quarter of 2022 compared to $10.8 million of income in the third quarter of 2021, a decrease of $86.2 million. The decrease is due to an expected loss on disposal of $73.8 million, an increase in professional fees associated with the divestiture of a significant portion of the Meal Preparation business, an increase in interest expense due to rising interest rates, and unfavorable foreign currency exchange rate impacts between the U.S. and Canadian dollar. Refer to Note 7 of our Condensed Consolidated Financial Statements for additional details.
|
||
| Dollars | Percent | |||||||||||||
| (In millions) | ||||||||||||||
| 2021 Net sales | $ | 2,129.6 | ||||||||||||
| Pricing | 331.6 | 15.6 | % | |||||||||||
| Volume/mix | (0.9) | — | ||||||||||||
| Foreign currency | (2.5) | (0.2) | ||||||||||||
| 2022 Net sales | $ | 2,457.8 | 15.4 | % | ||||||||||
| Foreign currency | 0.2 | |||||||||||||
| Percent change in organic net sales | 15.6 | % | ||||||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2022 | 2021 | |||||||||||||
| (In millions) | ||||||||||||||
| Net Cash Flows Provided By (Used In): | ||||||||||||||
| Operating activities of continuing operations | $ | (90.4) | $ | (57.0) | ||||||||||
| Investing activities of continuing operations | (56.5) | (53.1) | ||||||||||||
| Financing activities of continuing operations | (21.8) | (357.9) | ||||||||||||
| Cash flows from discontinued operations | (59.9) | 171.3 | ||||||||||||
|
Net cash used in operating activities from continuing operations was $90.4 million in the first nine months of 2022 compared to $57.0 million in the first nine months of 2021, an increase in cash used of $33.4 million. The increase was primarily attributable to lower cash earnings, which reflect the impact of commodity and freight cost inflation. Working capital changes have been impacted by higher sales as a result of price increases in response to commodity and freight cost inflation, which have increased receivables and inventories. This was partially offset by an increase in cash flow from accounts payable due to improved working capital management, lower incentive compensation paid in the first quarter of 2022 compared to the first quarter of 2021 based on prior year performance, lower cash paid on interest due to debt refinancing in 2021, and an increase in cash flows from the Receivables Sales Program. Refer to Note 5 to our Condensed Consolidated Financial Statements for additional information. The Company's working capital management emphasis continues to be focused on driving faster collection of receivables and extending vendor terms.
|
||
|
Net cash used in investing activities from continuing operations was $56.5 million in the first nine months of 2022 compared to $53.1 million in the first nine months of 2021, an increase in cash used of $3.4 million. This was primarily driven by the non-recurrence of proceeds received from the sale of our investments during the first quarter of 2021 as the Company entered into a total return swap contract to hedge the market risk associated with the unfunded portion of the Company's deferred compensation liability (refer to Note 19 to our Condensed Consolidated Financial Statements for additional information). This was partially offset by lower capital expenditures and increased proceeds received from the sale of fixed assets.
|
||
|
Net cash used in financing activities from continuing operations was $21.8 million in the first nine months of 2022 compared to $357.9 million in the first nine months of 2021, a decrease in cash used of $336.1 million. The decrease in cash used is attributable to the debt refinancing in the prior year, which included the redemption of the 2024 Notes of $602.9 million. Additionally, there was $25.0 million of common stock repurchases during the first nine months of 2021, which contributed to the decrease in cash used. This was partially offset by the Amendment to the Credit Agreement in the prior year, which resulted in an increase in Term Loan balances of $304.0 million.
|
||
|
Net cash used in discontinued operations was $59.9 million in the first nine months of 2022 compared to net cash provided by discontinued operations of $171.3 million, an increase in cash used of $231.2 million. The increase in cash used in the first nine months of 2021 is primarily due to the non-recurrence from the proceeds received of $88.0 million from the completion of the sale of the Ready-to-eat Cereal business on June 1, 2021. Additionally, the increase was attributable to lower cash earnings from a significant portion of the Meal Preparation business, which reflect the impact of commodity and freight cost inflation. Working capital changes have been impacted by higher sales as a result of price increases in response to commodity and freight cost inflation, which have increased receivables and inventories. This was partially offset by an increase in cash flow from accounts payable due to improved working capital management. Refer to Note 7 to our Condensed Consolidated Financial Statements for additional information.
|
||
| TreeHouse Foods, Inc. and Guarantor Subsidiaries | ||||||||
| Summarized Statement of Operations | Nine Months Ended September 30, 2022 | |||||||
| (unaudited, in millions) | ||||||||
| Net sales | $ | 2,423.8 | ||||||
| Gross profit (1) | 329.5 | |||||||
| Net loss from continuing operations | (34.9) | |||||||
| Net loss from discontinued operations | (72.8) | |||||||
| Net loss | (107.7) | |||||||
| TreeHouse Foods, Inc. and Guarantor Subsidiaries | ||||||||||||||
| Summarized Balance Sheet | September 30, 2022 | December 31, 2021 | ||||||||||||
| (unaudited, in millions) | ||||||||||||||
| Current assets | $ | 1,929.7 | $ | 1,910.0 | ||||||||||
| Noncurrent assets | 2,769.2 | 2,813.7 | ||||||||||||
| Current liabilities | 1,144.6 | 1,047.2 | ||||||||||||
| Noncurrent liabilities (2) | 2,115.2 | 2,164.8 | ||||||||||||
|
Three Months Ended
September 30, 2022 |
Nine Months Ended
September 30, 2022 |
|||||||||||||||||||||||||||||||||||||||||||
| Continuing Operations | Discontinued Operations | Total | Continuing Operations | Discontinued Operations | Total | |||||||||||||||||||||||||||||||||||||||
| (unaudited) | (unaudited) | |||||||||||||||||||||||||||||||||||||||||||
| Diluted earnings (loss) per share (GAAP) | $ | (0.27) | $ | (1.34) | $ | (1.61) | $ | (1.00) | $ | (1.19) | $ | (2.19) | ||||||||||||||||||||||||||||||||
| Loss (gain) on sale of business | (1) | — | 1.31 | 1.31 | — | 1.31 | 1.31 | |||||||||||||||||||||||||||||||||||||
| Growth, reinvestment, restructuring programs & other | (2) | 0.40 | 0.02 | 0.42 | 1.18 | 0.09 | 1.26 | |||||||||||||||||||||||||||||||||||||
| Central services and conveyed employee costs | (3) | 0.38 | (0.38) | — | 1.15 | (1.15) | — | |||||||||||||||||||||||||||||||||||||
| Divestiture, acquisition, integration, and related costs | (4) | 0.15 | 0.17 | 0.31 | 0.33 | 0.55 | 0.88 | |||||||||||||||||||||||||||||||||||||
| Foreign currency loss (gain) on re-measurement of intercompany notes | (5) | 0.03 | 0.06 | 0.09 | 0.02 | 0.05 | 0.07 | |||||||||||||||||||||||||||||||||||||
| Shareholder activism | (6) | 0.01 | — | 0.01 | 0.04 | — | 0.04 | |||||||||||||||||||||||||||||||||||||
| Litigation matter | (7) | — | — | — | 0.01 | — | 0.01 | |||||||||||||||||||||||||||||||||||||
| Tax indemnification | (8) | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Mark-to-market adjustments | (9) | (0.30) | — | (0.30) | (1.41) | — | (1.41) | |||||||||||||||||||||||||||||||||||||
| COVID-19 | (10) | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Loss on extinguishment of debt | (11) | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Taxes on adjusting items | (0.10) | 0.05 | (0.05) | (0.13) | 0.16 | 0.03 | ||||||||||||||||||||||||||||||||||||||
| Adjusted diluted EPS (Non-GAAP) | $ | 0.30 | $ | (0.11) | $ | 0.18 | $ | 0.19 | $ | (0.18) | $ | — | ||||||||||||||||||||||||||||||||
|
Three Months Ended
September 30, 2021 |
Nine Months Ended
September 30, 2021 |
|||||||||||||||||||||||||||||||||||||||||||
| Continuing Operations | Discontinued Operations | Total | Continuing Operations | Discontinued Operations | Total | |||||||||||||||||||||||||||||||||||||||
| (unaudited) | (unaudited) | |||||||||||||||||||||||||||||||||||||||||||
| Diluted earnings (loss) per share (GAAP) | $ | (0.07) | $ | 0.19 | $ | 0.12 | $ | (0.90) | $ | 1.19 | $ | 0.30 | ||||||||||||||||||||||||||||||||
| Loss (gain) on sale of business | (1) | — | — | — | — | (0.33) | (0.33) | |||||||||||||||||||||||||||||||||||||
| Growth, reinvestment, restructuring programs & other | (2) | 0.30 | 0.01 | 0.31 | 1.02 | 0.03 | 1.05 | |||||||||||||||||||||||||||||||||||||
| Central services and conveyed employee costs | (3) | 0.32 | (0.32) | — | 1.09 | (1.09) | — | |||||||||||||||||||||||||||||||||||||
| Divestiture, acquisition, integration, and related costs | (4) | 0.04 | 0.09 | 0.14 | 0.05 | 0.30 | 0.35 | |||||||||||||||||||||||||||||||||||||
| Foreign currency loss (gain) on re-measurement of intercompany notes | (5) | 0.01 | 0.02 | 0.04 | — | (0.01) | (0.01) | |||||||||||||||||||||||||||||||||||||
| Shareholder activism | (6) | 0.02 | — | 0.02 | 0.07 | — | 0.07 | |||||||||||||||||||||||||||||||||||||
| Litigation matter | (7) | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Tax indemnification | (8) | 0.02 | 0.02 | 0.04 | 0.03 | 0.02 | 0.05 | |||||||||||||||||||||||||||||||||||||
| Mark-to-market adjustments | (9) | (0.08) | (0.01) | (0.09) | (0.59) | — | (0.59) | |||||||||||||||||||||||||||||||||||||
| COVID-19 | (10) | 0.05 | 0.01 | 0.06 | 0.24 | 0.05 | 0.29 | |||||||||||||||||||||||||||||||||||||
| Loss on extinguishment of debt | (11) | — | — | — | 0.26 | — | 0.26 | |||||||||||||||||||||||||||||||||||||
| Taxes on adjusting items | (0.19) | 0.03 | (0.18) | (0.56) | 0.24 | (0.33) | ||||||||||||||||||||||||||||||||||||||
| Adjusted diluted EPS (Non-GAAP) | $ | 0.42 | $ | 0.04 | $ | 0.46 | $ | 0.71 | $ | 0.40 | $ | 1.11 | ||||||||||||||||||||||||||||||||
| (1) |
For the three and nine months ended September 30, 2022, the Company recognized an expected loss on disposal of a significant portion of the Meal Preparation business of $73.8 million. For the nine months ended September 30, 2021, the Company recognized a gain on the sale of the RTE Cereal business of $18.4 million.
|
||||
|
Refer to Note 7 to our Condensed Consolidated Financial Statements for additional information.
|
|||||
| (2) |
The Company's growth, reinvestment, and restructuring activities are part of an enterprise-wide transformation to improve long-term growth and profitability for the Company. For the three months ended September 30, 2022 and 2021, the Company incurred growth, reinvestment, and restructuring program costs of approximately $23.6 million and $17.4 million, respectively. For the nine months ended September 30, 2022 and 2021, the Company incurred growth, reinvestment, and restructuring program costs of approximately $71.3 million and $59.3 million, respectively. Additionally, the Company recognized other items affecting comparability including regulatory compliance cost reimbursements related to changes in nutrition labeling requirements. There were no other items recognized during the three and nine months ended September 30, 2022. These other items were approximately $(0.1) million for the nine months ended September 30, 2021.
|
||||
|
Refer to Note 3 to our Condensed Consolidated Financial Statements for additional information on a continuing operations basis.
|
|||||
| (3) |
As a result of the sale of a significant portion of the Meal Preparation business, the Company identified two items affecting comparability – 1) central service costs and 2) conveyed employee costs.
1) The Company has historically provided central services to the Meal Preparation business including, but not limited to, IT and financial shared services, procurement and order processing, customer service, warehousing, logistics, and customs. These costs were historically incurred by TreeHouse and include employee and non-employee expenses to support the services. For the three months ended September 30, 2022 and 2021, central service costs were approximately $13.4 million in both periods. For the nine months ended September 30, 2022 and 2021, central service costs were approximately $40.2 million in both periods.
2) Conveyed employee costs represent compensation costs for employees that were not historically dedicated to the sold business and transferred to the buyer after the sale. For the three months ended September 30, 2022 and 2021, conveyed employee costs were approximately $8.1 million and $4.7 million, respectively. For the nine months ended September 30, 2022 and 2021, conveyed employee costs were approximately $24.8 million and $20.9 million, respectively.
|
||||
| (4) | Divestiture, acquisition, integration, and related costs represent costs associated with completed and potential divestitures, completed and potential acquisitions, and the related integration of the acquisitions. | ||||
|
Refer to Note 7 to our Condensed Consolidated Financial Statements for additional information.
|
|||||
| (5) |
The Company has foreign currency denominated intercompany loans and incurred foreign currency losses of $5.0 million and $2.1 million for the three months ended September 30, 2022 and 2021, respectively, to re-measure the loans at quarter end. For the nine months ended September 30, 2022 and 2021, the Company incurred foreign currency losses of $4.1 million and foreign currency gains of $0.7 million, respectively. These charges are non-cash and the loans are eliminated in consolidation.
|
||||
| (6) | The Company incurred fees related to shareholder activism which include directly applicable third-party advisory and professional service fees. | ||||
| (7) |
During the nine months ended September 30, 2022, the Company recognized $0.4 million incremental expense for the settlement payment of the $9.0 million accrual related to a litigation matter challenging wage and hour practices at three former manufacturing facilities in California.
|
||||
| (8) | Tax indemnification represents the non-cash write off of indemnification assets that were recorded in connection with acquisitions from prior years. These write-offs arose as a result of the related uncertain tax position being released due to the statute of limitation lapse or settlement with taxing authorities. | ||||
| (9) |
The Company's derivative contracts are marked-to-market each period. The non-cash unrealized changes in fair value recognized in Other income, net within the Condensed Consolidated Statements of Operations are treated as Non-GAAP adjustments. As the contracts are settled, realized gains and losses are recognized, and only the mark-to-market impacts are treated as Non-GAAP adjustments.
|
||||
|
Refer to Note 19 to our Condensed Consolidated Financial Statements for additional information.
|
|||||
| (10) |
During 2021, the Company incurred incremental expenses directly attributable to our response to the COVID-19 pandemic, which included additional protective equipment for employees and additional sanitation measures. These costs were approximately $1.1 million and $14.6 million for the three and nine months ended September 30, 2021, respectively. Additionally, the Company incurred income tax expense due to a change in the amount of the total benefit recognized from the enactment of the CARES Act of approximately $1.9 million for the three and nine months ended September 30, 2021.
|
||||
| (11) |
For the nine months ended September 30, 2021, the Company incurred a loss on extinguishment of debt totaling $14.4 million, which included a premium of $9.0 million and a write off of deferred financing costs of $5.4 million in connection with the redemption of its 2024 Notes and Credit Agreement refinancing.
|
||||
|
Refer to Note 12 to our Condensed Consolidated Financial Statements for additional information.
|
|||||
| Three Months Ended September 30, 2022 | Nine Months Ended September 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||
| Continuing Operations | Discontinued Operations | Total | Continuing Operations | Discontinued Operations | Total | ||||||||||||||||||||||||||||||||||||||||||
| (unaudited in millions) | |||||||||||||||||||||||||||||||||||||||||||||||
| Net (loss) income (GAAP) | $ | (15.1) | $ | (75.4) | $ | (90.5) | $ | (56.2) | $ | (66.7) | $ | (122.9) | |||||||||||||||||||||||||||||||||||
| Loss (gain) on sale of business | (1) | — | 73.8 | 73.8 | — | 73.8 | 73.8 | ||||||||||||||||||||||||||||||||||||||||
| Growth, reinvestment, restructuring programs & other | (2) | 22.4 | 1.2 | 23.6 | 66.4 | 4.9 | 71.3 | ||||||||||||||||||||||||||||||||||||||||
| Central services and conveyed employee costs | (3) | 21.5 | (21.5) | — | 65.0 | (65.0) | — | ||||||||||||||||||||||||||||||||||||||||
| Divestiture, acquisition, integration, and related costs | (4) | 8.2 | 9.4 | 17.6 | 18.4 | 31.0 | 49.4 | ||||||||||||||||||||||||||||||||||||||||
| Foreign currency loss (gain) on re-measurement of intercompany notes | (5) | 1.8 | 3.2 | 5.0 | 1.4 | 2.7 | 4.1 | ||||||||||||||||||||||||||||||||||||||||
| Shareholder activism | (6) | 0.4 | — | 0.4 | 2.1 | — | 2.1 | ||||||||||||||||||||||||||||||||||||||||
| Litigation matter | (7) | — | — | — | 0.4 | — | 0.4 | ||||||||||||||||||||||||||||||||||||||||
| Tax indemnification | (8) | — | — | — | — | 0.1 | 0.1 | ||||||||||||||||||||||||||||||||||||||||
| Mark-to-market adjustments | (9) | (17.1) | (0.1) | (17.2) | (79.4) | (0.1) | (79.5) | ||||||||||||||||||||||||||||||||||||||||
| COVID-19 | (10) | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
| Loss on extinguishment of debt | (11) | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
| Less: Taxes on adjusting items | (5.0) | 2.6 | (2.4) | (7.5) | 9.3 | 1.8 | |||||||||||||||||||||||||||||||||||||||||
| Adjusted net income (loss) (Non-GAAP) | 17.1 | (6.8) | 10.3 | 10.6 | (10.0) | 0.6 | |||||||||||||||||||||||||||||||||||||||||
| Interest expense | 17.5 | 5.3 | 22.8 | 51.2 | 11.4 | 62.6 | |||||||||||||||||||||||||||||||||||||||||
| Interest income | (0.1) | — | (0.1) | (4.4) | — | (4.4) | |||||||||||||||||||||||||||||||||||||||||
| Income taxes | 2.0 | 0.6 | 2.6 | (4.8) | 4.6 | (0.2) | |||||||||||||||||||||||||||||||||||||||||
| Add: Taxes on adjusting items | 5.0 | (2.6) | 2.4 | 7.5 | (9.3) | (1.8) | |||||||||||||||||||||||||||||||||||||||||
| Adjusted EBIT (Non-GAAP) | 41.5 | (3.5) | 38.0 | 60.1 | (3.3) | 56.8 | |||||||||||||||||||||||||||||||||||||||||
| Depreciation and amortization | (12) | 35.1 | 16.3 | 51.4 | 106.9 | 49.6 | 156.5 | ||||||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA (Non-GAAP) | 76.6 | 12.8 | 89.4 | 167.0 | 46.3 | 213.3 | |||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation expense | (13) | 3.8 | 0.7 | 4.5 | 10.7 | 2.2 | 12.9 | ||||||||||||||||||||||||||||||||||||||||
| Adjusted EBITDAS (Non-GAAP) | $ | 80.4 | $ | 13.5 | $ | 93.9 | $ | 177.7 | $ | 48.5 | $ | 226.2 | |||||||||||||||||||||||||||||||||||
| Net (loss) income margin | (1.7) | % | (17.8) | % | (7.0) | % | (2.3) | % | (5.7) | % | (3.4) | % | |||||||||||||||||||||||||||||||||||
| Adjusted net income (loss) margin | 2.0 | % | (1.6) | % | 0.8 | % | 0.4 | % | (0.8) | % | — | % | |||||||||||||||||||||||||||||||||||
| Adjusted EBIT margin | 4.7 | % | (0.8) | % | 2.9 | % | 2.4 | % | (0.3) | % | 1.6 | % | |||||||||||||||||||||||||||||||||||
| Adjusted EBITDA margin | 8.8 | % | 3.0 | % | 6.9 | % | 6.8 | % | 3.9 | % | 5.9 | % | |||||||||||||||||||||||||||||||||||
| Adjusted EBITDAS margin | 9.2 | % | 3.2 | % | 7.2 | % | 7.2 | % | 4.1 | % | 6.2 | % | |||||||||||||||||||||||||||||||||||
| Three Months Ended September 30, 2021 | Nine Months Ended September 30, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||
| Continuing Operations | Discontinued Operations | Total | Continuing Operations | Discontinued Operations | Total | ||||||||||||||||||||||||||||||||||||||||||
| (unaudited in millions) | |||||||||||||||||||||||||||||||||||||||||||||||
| Net (loss) income (GAAP) | $ | (4.1) | $ | 10.8 | $ | 6.7 | $ | (50.1) | $ | 66.7 | $ | 16.6 | |||||||||||||||||||||||||||||||||||
| Loss (gain) on sale of business | (1) | — | — | — | — | (18.4) | (18.4) | ||||||||||||||||||||||||||||||||||||||||
| Growth, reinvestment, restructuring programs & other | (2) | 16.9 | 0.5 | 17.4 | 57.5 | 1.7 | 59.2 | ||||||||||||||||||||||||||||||||||||||||
| Central services and conveyed employee costs | (3) | 18.1 | (18.1) | — | 61.1 | (61.1) | — | ||||||||||||||||||||||||||||||||||||||||
| Divestiture, acquisition, integration, and related costs | (4) | 2.4 | 5.2 | 7.6 | 3.0 | 16.8 | 19.8 | ||||||||||||||||||||||||||||||||||||||||
| Foreign currency loss (gain) on re-measurement of intercompany notes | (5) | 0.8 | 1.3 | 2.1 | (0.2) | (0.5) | (0.7) | ||||||||||||||||||||||||||||||||||||||||
| Shareholder activism | (6) | 0.9 | — | 0.9 | 4.0 | — | 4.0 | ||||||||||||||||||||||||||||||||||||||||
| Litigation matter | (7) | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
| Tax indemnification | (8) | 1.5 | 1.2 | 2.7 | 1.7 | 1.2 | 2.9 | ||||||||||||||||||||||||||||||||||||||||
| Mark-to-market adjustments | (9) | (4.7) | (0.6) | (5.3) | (33.3) | 0.2 | (33.1) | ||||||||||||||||||||||||||||||||||||||||
| COVID-19 | (10) | 2.5 | 0.5 | 3.0 | 13.6 | 2.9 | 16.5 | ||||||||||||||||||||||||||||||||||||||||
| Loss on extinguishment of debt | (11) | — | — | — | 14.4 | — | 14.4 | ||||||||||||||||||||||||||||||||||||||||
| Less: Taxes on adjusting items | (10.9) | 1.5 | (9.4) | (31.7) | 12.9 | (18.8) | |||||||||||||||||||||||||||||||||||||||||
| Adjusted net income (loss) (Non-GAAP) | 23.4 | 2.3 | 25.7 | 40.0 | 22.4 | 62.4 | |||||||||||||||||||||||||||||||||||||||||
| Interest expense | 16.5 | 2.3 | 18.8 | 55.5 | 7.5 | 63.0 | |||||||||||||||||||||||||||||||||||||||||
| Interest income | — | — | — | (4.1) | — | (4.1) | |||||||||||||||||||||||||||||||||||||||||
| Income taxes (excluding COVID-19 income tax adjustments) | (2.3) | 1.9 | (0.4) | (16.9) | 19.8 | 2.9 | |||||||||||||||||||||||||||||||||||||||||
| Add: Taxes on adjusting items | 10.9 | (1.5) | 9.4 | 31.7 | (12.9) | 18.8 | |||||||||||||||||||||||||||||||||||||||||
| Adjusted EBIT (Non-GAAP) | 48.5 | 5.0 | 53.5 | 106.2 | 36.8 | 143.0 | |||||||||||||||||||||||||||||||||||||||||
| Depreciation and amortization | (12) | 37.3 | 16.1 | 53.4 | 112.3 | 48.9 | 161.2 | ||||||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA (Non-GAAP) | 85.8 | 21.1 | 106.9 | 218.5 | 85.7 | 304.2 | |||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation expense | (13) | 1.1 | 0.6 | 1.7 | 8.3 | 2.2 | 10.5 | ||||||||||||||||||||||||||||||||||||||||
| Adjusted EBITDAS (Non-GAAP) | $ | 86.9 | $ | 21.7 | $ | 108.6 | $ | 226.8 | $ | 87.9 | $ | 314.7 | |||||||||||||||||||||||||||||||||||
| Net (loss) income margin | (0.5) | % | 3.1 | % | 0.6 | % | (2.4) | % | 6.0 | % | 0.5 | % | |||||||||||||||||||||||||||||||||||
| Adjusted net income (loss) margin | 3.1 | % | 0.7 | % | 2.3 | % | 1.9 | % | 2.0 | % | 1.9 | % | |||||||||||||||||||||||||||||||||||
| Adjusted EBIT margin | 6.5 | % | 1.4 | % | 4.9 | % | 5.0 | % | 3.3 | % | 4.4 | % | |||||||||||||||||||||||||||||||||||
| Adjusted EBITDA margin | 11.4 | % | 6.0 | % | 9.7 | % | 10.3 | % | 7.7 | % | 9.4 | % | |||||||||||||||||||||||||||||||||||
| Adjusted EBITDAS margin | 11.6 | % | 6.2 | % | 9.9 | % | 10.6 | % | 7.9 | % | 9.7 | % | |||||||||||||||||||||||||||||||||||
| Location in Condensed | Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||||
| Consolidated Statements of Operations | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||||||||||||||
| (unaudited in millions) | ||||||||||||||||||||||||||||||||||||||
| (1) | Loss (gain) on sale of business | Net (loss) income from discontinued operations | $ | 73.8 | $ | — | $ | 73.8 | $ | (18.4) | ||||||||||||||||||||||||||||
| (2) | Growth, reinvestment, restructuring programs & other | Other operating expense, net | 22.4 | 16.9 | 66.4 | 57.6 | ||||||||||||||||||||||||||||||||
| Cost of sales | — | — | — | (0.1) | ||||||||||||||||||||||||||||||||||
| Net (loss) income from discontinued operations | 1.2 | 0.5 | 4.9 | 1.7 | ||||||||||||||||||||||||||||||||||
| (3) | Central services and conveyed employee costs | General and administrative | 16.5 | 14.3 | 50.1 | 47.6 | ||||||||||||||||||||||||||||||||
| Cost of sales | 5.0 | 3.8 | 14.9 | 13.5 | ||||||||||||||||||||||||||||||||||
| Net (loss) income from discontinued operations | (21.5) | (18.1) | (65.0) | (61.1) | ||||||||||||||||||||||||||||||||||
| (4) | Divestiture, acquisition, integration, and related costs | General and administrative | 7.2 | 2.2 | 15.7 | 2.5 | ||||||||||||||||||||||||||||||||
| Cost of sales | — | 0.2 | 1.6 | 0.4 | ||||||||||||||||||||||||||||||||||
| Other operating expense, net | 1.0 | — | 1.1 | 0.1 | ||||||||||||||||||||||||||||||||||
| Net (loss) income from discontinued operations | 9.4 | 5.2 | 31.0 | 16.8 | ||||||||||||||||||||||||||||||||||
| (5) | Foreign currency loss (gain) on re-measurement of intercompany notes | Loss (gain) on foreign currency exchange | 1.8 | 0.8 | 1.4 | (0.2) | ||||||||||||||||||||||||||||||||
| Net (loss) income from discontinued operations | 3.2 | 1.3 | 2.7 | (0.5) | ||||||||||||||||||||||||||||||||||
| (6) | Shareholder activism | General and administrative | 0.4 | 0.9 | 2.1 | 4.0 | ||||||||||||||||||||||||||||||||
| (7) | Litigation matter | General and administrative | — | — | 0.4 | — | ||||||||||||||||||||||||||||||||
| (8) | Tax indemnification | Other income, net | — | 1.5 | — | 1.7 | ||||||||||||||||||||||||||||||||
| Net (loss) income from discontinued operations | — | 1.2 | 0.1 | 1.2 | ||||||||||||||||||||||||||||||||||
| (9) | Mark-to-market adjustments | Other income, net | (17.1) | (4.7) | (79.4) | (33.3) | ||||||||||||||||||||||||||||||||
| Net (loss) income from discontinued operations | (0.1) | (0.6) | (0.1) | 0.2 | ||||||||||||||||||||||||||||||||||
| (10) | COVID-19 | Cost of sales | — | 0.6 | — | 11.7 | ||||||||||||||||||||||||||||||||
| Income tax expense (benefit) | — | 1.9 | — | 1.9 | ||||||||||||||||||||||||||||||||||
| Net (loss) income from discontinued operations | — | 0.5 | — | 2.9 | ||||||||||||||||||||||||||||||||||
| (11) | Loss on extinguishment of debt | Loss on extinguishment of debt | — | — | — | 14.4 | ||||||||||||||||||||||||||||||||
| (12) | Depreciation and amortization included as an adjusting item | Net (loss) income from discontinued operations | (11.0) | — | (11.0) | — | ||||||||||||||||||||||||||||||||
| (13) | Stock-based compensation expense included as an adjusting item | Other operating expense, net | 2.3 | 0.3 | 4.5 | 1.8 | ||||||||||||||||||||||||||||||||
| Net (loss) income from discontinued operations | — | (0.3) | (0.5) | (1.0) | ||||||||||||||||||||||||||||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2022 | 2021 | |||||||||||||
| (In millions) | ||||||||||||||
| Cash flow used in operating activities from continuing operations (GAAP) | $ | (90.4) | $ | (57.0) | ||||||||||
| Less: Capital expenditures | (61.3) | (70.4) | ||||||||||||
| Free cash flow from continuing operations (Non-GAAP) | $ | (151.7) | $ | (127.4) | ||||||||||
| 2.1 | |||||
| 3.1 | |||||
| 3.2 | |||||
| 10.1 | |||||
| 10.2 | |||||
| 22* | |||||
| 31.1* | |||||
| 31.2* | |||||
| 32.1* | |||||
| 32.2* | |||||
| 101.INS* | Inline XBRL Instance Document. | ||||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document. | ||||
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | ||||
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document. | ||||
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | ||||
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document. | ||||
| 104* |
The cover page from TreeHouse Foods, Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in Inline XBRL (included as Exhibit 101).
|
||||
| TREEHOUSE FOODS, INC. | |||||
|
Date: November 7, 2022
|
/s/ Patrick M. O'Donnell | ||||
| Patrick M. O'Donnell | |||||
| Interim Chief Financial Officer and Chief Accounting Officer | |||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Tyson Foods, Inc. | TSN |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|